Natalie Hajduga
Dr Richard McNally
Dr Vida Zohoori
Professor Vikki Rand
| Exposure to fluoride and risk of primary bone cancer: A systematic review | 2025 |
|
Dr Simon Bomken
Dr Amir Enshaei
Dr Ed Schwalbe
Dr Aneta Mikulasova
Dr Masood Zaka
et al. | Molecular characterisation and clinical outcome of B-cell precursor acute lymphoblastic leukaemia with IG-MYC rearrangement | 2023 |
|
Dr Alex Blain
Dr Christopher Bacon
Professor Vikki Rand
Professor Matthew Collin
Dr Christopher Carey
et al. | Spatial and molecular profiling of the mononuclear phagocyte network in classic Hodgkin lymphoma | 2023 |
|
Dr Alex Newman
Dr Masood Zaka
Dr Peixun Zhou
Dr Alex Blain
Dr Amy Erhorn
et al. | Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma | 2022 |
|
Dr Marina Danilenko
Dr Claire Keeling
Dr Stephen Crosier
Dr Martina Finetti
Dr Daniel Williamson
et al. | Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma development | 2022 |
|
Dr Ugo Offor
Dr Christopher Bacon
Dr Jessica Roberts
Jason Powell
Dr Malcolm Brodlie
et al. | Transplantation For Congenital Heart Disease Is Associated With An Increased Risk Of Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder In Children | 2021 |
|
Dr Katarzyna Szoltysek
Dr Carmela Ciardullo
Dr Peixun Zhou
Dr Anna Walaszczyk
Dr Elaine Willmore
et al. | Dap kinase-related apoptosis-inducing protein kinase 2 (Drak2) is a key regulator and molecular marker in chronic lymphocytic leukemia | 2020 |
|
